about
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanLifestyle changes in women with polycystic ovary syndromeMetformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysisDietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in SingaporeEngaging rural women in healthy lifestyle programs: insights from a randomized controlled trial.The Association of a Mediterranean-Style Diet Pattern with Polycystic Ovary Syndrome Status in a Community Cohort Study.Dietary therapy in polycystic ovary syndrome.Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Polycystic ovary syndrome and weight management.Exercise therapy in polycystic ovary syndrome: a systematic review.The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome.Weight management practices associated with PCOS and their relationships with diet and physical activity.Treatment with high dose salicylates improves cardiometabolic parameters: Meta-analysis of randomized controlled trials.Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity.The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options.The effect of antenatal dietary and lifestyle advice for women who are overweight or obese on emotional well-being: the LIMIT randomized trial.Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.The satiating effect of dietary protein is unrelated to postprandial ghrelin secretion.Assessing self-efficacy and self-help methods in women with and without Polycystic Ovary Syndrome.Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women.The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome.Vitamin D is independently associated with depression in overweight women with and without PCOS.Evaluation of a smartphone nutrition and physical activity application to provide lifestyle advice to pregnant women: The SNAPP randomised trial.Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome.Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline.Polycystic ovary syndrome and adverse pregnancy outcomes: current state of knowledge, challenges and potential implications for practice.Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity.Vascular function in the diagnostic categories of polycystic ovary syndrome.Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
P50
Q21245262-826C3D7C-BA4B-40DA-A295-4379DB58408AQ24234000-75F09B2A-9A30-4414-A515-39E5F012F031Q28088433-0C370298-5620-4C08-A77B-0215E6B75CCFQ34348028-86D8AA58-C2E1-48BA-8698-C70C08EE150AQ36053388-9F27A0B3-8883-47FD-B61B-5910D8F45D7AQ36070789-668B65AA-15D0-4F67-8012-69CFD3725B4CQ36246793-5D29F2C6-B168-4320-B799-E6FC6FE671D8Q37052801-A9C56A67-56A1-410C-A47C-34AA27CCD51BQ37343173-D4CBFC5C-68FC-476C-BA1E-EE72CEC055C2Q37412812-FC1CF9CD-A73B-4705-8F55-EA34515EC0F4Q37699367-DBB4D055-8F62-4A95-BCCE-72AC0B57FEE4Q37787632-929BD5B6-77E7-4881-9993-B0983AAFACC7Q38541539-72D814AC-E935-4B70-BE78-451A99AC2E12Q38772605-101A0AF5-F827-4913-B29E-855EAB9EF8E6Q38776400-6537AE49-57B6-41AE-921C-F3AFC361252CQ38818596-A9AF60B5-A342-4625-A03F-015E9A43925DQ39049919-C2969C2A-AEF9-4575-9E21-D25EDA621649Q39401759-D7D5680C-AB9E-49C9-9B45-54C48A2EC99AQ39830101-B95D9C01-8B04-44D4-9E60-C978B653C081Q39912489-32D95845-005A-4941-8EC6-0C64B449FDCFQ41088181-AA686394-C784-44B2-9330-8B49F18F0BF5Q43260422-B0F906DF-AD18-42C2-A639-0205E9B701EAQ43668598-DD04E67A-BD32-4763-8164-36BCDC2350DAQ46074422-E90441C9-FAC4-47D3-94FF-D50CEE25F68BQ46238171-58EE3B5D-E0A6-496F-9287-6FA3C64414D2Q46319185-1CD7BFAE-BF37-482E-94B8-2DB7A273051CQ46598413-9FA9E3EA-18E8-4003-8A7D-35342650C0AEQ46960170-C20AE7E9-D588-4A26-8AF7-65E72F7E91A7Q47225779-51FD9754-48A6-428D-B1D6-FA2A14DCFA3DQ47278837-8F55F514-441D-4640-B924-BD4D51FB1F2BQ47288137-5D9B9CA5-2FA8-4C41-8870-CA11F3D07E89Q47436489-5AAE6078-3D84-4A61-B38A-471E1A53FC3DQ48181786-E24AC65F-09D9-43E9-B231-CF14AA9B7B9DQ48183362-7C09C583-01CC-4E0F-B75B-3907F288EB4CQ48456588-053C0BFA-EE01-4CFF-84EB-B43770427A1EQ48589482-3EC8D446-B5D5-4B41-ACA6-0C9BD9E63DCFQ49823391-C46FC528-3205-4D2C-9FBE-BE833547BB12Q50628402-CA04D938-A93D-4EBE-90AA-93BA5EE25D6FQ51031054-8D7A702F-2819-4307-87D9-FE42E123B1A4Q51487246-8B8F0288-498B-49E1-902E-11D17A46D5D6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lisa J Moran
@ast
Lisa J Moran
@en
Lisa J Moran
@es
Lisa J Moran
@sl
type
label
Lisa J Moran
@ast
Lisa J Moran
@en
Lisa J Moran
@es
Lisa J Moran
@sl
prefLabel
Lisa J Moran
@ast
Lisa J Moran
@en
Lisa J Moran
@es
Lisa J Moran
@sl
P106
P21
P31
P496
0000-0001-5772-6484